Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer By Ogkologos - November 4, 2024 1890 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Drug Combination May Target the Unique Metabolism of Leukemia Stem Cells December 14, 2018 A new target to slow down ageing and reduce blood cancer... June 29, 2023 Insights Into the Biology of Response and Resistance to MAPK Pathway... October 16, 2024 Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine... March 1, 2024 Load more HOT NEWS ESMO Announces Results of 2025 Elections Bullies Make Fun Of Little Girl Over Cancer Scars, Her Mom... Study Reinforces Treatment Idea for Cancer with Microsatellite Instability Sound Waves Can Target Lymph Nodes And Help Kill Breast Cancer...
